Market Outlook
The global Neurovascular Devices market size was valued at USD 190 million in 2022 and is forecast to a readjusted size of USD 272.1 million by 2029 with a CAGR of 5.3% during review period.
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Top players in the neurovascular devices market are Stryker Corporation and Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Abbott Laboratories, W. L. Gore & Associates, Microport Scientific Corporation and some others are also key players in this field. Geographically, the neurovascular devices market is classified into North America, Europe, Japan, China and The Rest. North America dominates the global market, followed by Europe and Japan.
On the basis of product, the neurovascular devices market is classified into four major segments—aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is the largest and accounts for about 37% of the global neurovascular devices market. Neurovascular devices are widely used in hospitals, clinics and ambulatory surgical units.
This report is a detailed and comprehensive analysis for global Neurovascular Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neurovascular Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Neurovascular Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Neurovascular Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Neurovascular Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurovascular Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurovascular Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Stryker Corporation
Johnson & Johnson
Medtronic
Terumo
Penumbra
Microport Scientific Corporation
Abbott Vascular
W. L. Gore & Associates
Segmentation By Type
Aneurysm Coiling & Embolization Devices
Cerebral Balloon Angioplasty & Stenting Systems
Support Devices
Neurothrombectomy Devices
Segmentation By Application
Hospitals
Clinics
Ambulatory Surgical Units
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Neurovascular Devices Market in 2025?
The neurovascular devices market benefits from strong technological advancements, improving patient outcomes through minimally invasive procedures. Additionally, rising awareness of stroke and other neurovascular diseases is driving demand for these devices. A growing elderly population further enhances the market's potential, with higher incidences of neurovascular disorders.
What weaknesses exist in the Neurovascular Devices Market in 2025?
High costs associated with advanced neurovascular devices can limit accessibility, especially in developing regions. Regulatory hurdles and long approval timelines also pose challenges. Moreover, a lack of skilled professionals to operate complex devices in certain markets may hinder market growth.
What opportunities can be capitalized on in the Neurovascular Devices Market in 2025?
There is significant potential in expanding into emerging markets where healthcare infrastructure is improving. Innovations like AI and robotics in neurovascular surgery present new avenues for growth. Additionally, increasing healthcare investments and collaborations between device manufacturers and hospitals could lead to more widespread adoption of advanced neurovascular treatments.
What threats could impact the Neurovascular Devices Market in 2025?
Competition from alternative treatments, such as pharmacological therapies, could affect device adoption. The rising cost of healthcare and economic downturns may reduce demand for premium devices. Moreover, ongoing concerns about cybersecurity in medical devices and potential device malfunctions could impact market confidence.
Market PESTEL Analysis
What political factors influence the Neurovascular Devices Market in 2025?
Government healthcare policies, especially in developed regions, strongly influence the adoption of neurovascular devices through reimbursements and regulations. Political instability in certain regions can disrupt the supply chain and hinder market growth. Additionally, healthcare reforms and public health initiatives aimed at treating neurovascular diseases may provide opportunities for market expansion.
How do economic factors impact the Neurovascular Devices Market in 2025?
Economic conditions play a crucial role in the affordability and accessibility of advanced neurovascular devices. In times of economic growth, healthcare budgets may increase, boosting market demand. However, economic downturns may lead to reduced healthcare spending, which could limit market opportunities, especially in lower-income regions.
What social factors affect the Neurovascular Devices Market in 2025?
Increasing awareness about stroke prevention and neurovascular health is positively influencing market growth. Social trends, such as an aging population in many parts of the world, drive a higher demand for neurovascular treatments. However, cultural perceptions around medical interventions in some regions may slow adoption rates.
How do technological factors influence the Neurovascular Devices Market in 2025?
Advancements in minimally invasive surgical techniques, robotics, and AI are revolutionizing neurovascular treatments, enhancing precision and reducing recovery times. However, the high costs of cutting-edge technology can be a barrier to entry in some healthcare systems, despite the potential for improved outcomes.
What environmental factors play a role in the Neurovascular Devices Market in 2025?
Environmental regulations on medical device production and disposal impact the manufacturing and lifecycle management of neurovascular devices. Sustainability concerns are leading to innovations in eco-friendly packaging and materials, which may add costs but are necessary for compliance and market acceptance.
What legal factors are significant for the Neurovascular Devices Market in 2025?
Regulatory frameworks governing medical device approval, such as the FDA in the U.S. or the European Medicines Agency (EMA) in Europe, significantly influence market dynamics. Stringent compliance requirements, along with intellectual property rights issues, can affect product development timelines and market entry for new devices.
Market SIPOC Analysis
Who are the suppliers in the Neurovascular Devices Market in 2025?
Suppliers in the neurovascular devices market include manufacturers of raw materials like metals, polymers, and electronic components. Additionally, companies specializing in medical device technology, such as imaging systems and robotic surgical tools, play a critical role. Healthcare equipment distributors and suppliers of packaging materials also contribute to the supply chain.
Who are the inputs involved in the Neurovascular Devices Market in 2025?
Key inputs include advanced raw materials for device construction, research and development data, skilled labor for manufacturing, and regulatory approvals. Investment in innovation and access to cutting-edge technologies, such as AI and machine learning, also serve as crucial inputs for the market.
What are the processes in the Neurovascular Devices Market in 2025?
The processes involve design and development of neurovascular devices, followed by rigorous testing and regulatory approval. Once approved, production takes place, focusing on quality control and manufacturing efficiency. Distribution networks then handle the delivery of devices to healthcare providers, ensuring training and post-sale support for medical professionals.
Who are the customers in the Neurovascular Devices Market in 2025?
Customers include hospitals, surgical centers, neurovascular specialists, and healthcare providers who are directly involved in treating stroke and other neurovascular disorders. Insurance companies and government health organizations also play a significant role in providing access to these devices for patients.
What are the outputs in the Neurovascular Devices Market in 2025?
Outputs include the various neurovascular devices such as stents, embolic protection devices, thrombectomy devices, and surgical tools used in neurovascular procedures. These outputs aim to improve patient outcomes by providing effective treatments for conditions like strokes, aneurysms, and vascular malformations. Additionally, post-operative monitoring solutions are also part of the market's outputs.
Market Porter's Five Forces
How does the threat of new entrants affect the Neurovascular Devices Market in 2025?
The threat of new entrants is moderate. While there are barriers to entry due to high capital requirements, regulatory hurdles, and the need for specialized knowledge, technological advancements and the growing demand for neurovascular treatments may attract new players. However, established companies with strong R&D and brand recognition maintain a competitive advantage.
What is the bargaining power of suppliers in the Neurovascular Devices Market in 2025?
The bargaining power of suppliers is moderate to high. Manufacturers rely on specialized materials and components for neurovascular devices, which are sourced from a limited number of suppliers. However, competition among suppliers and the ability to switch between suppliers for certain materials helps reduce their overall bargaining power.
How does the bargaining power of buyers impact the Neurovascular Devices Market in 2025?
The bargaining power of buyers is moderate. While healthcare providers and hospitals may have some negotiating power due to bulk purchases, the specialized nature of neurovascular devices and the lack of substitutes for many products reduce their overall influence. Additionally, insurance companies and government reimbursement policies also play a significant role in influencing prices.
What is the threat of substitute products or services in the Neurovascular Devices Market in 2025?
The threat of substitutes is low. Neurovascular devices are often essential for treating specific conditions like strokes and aneurysms, and there are few alternatives that can offer the same effectiveness. However, medical advancements in pharmacological treatments or non-invasive procedures may slowly pose a potential threat in the long term.
How does industry rivalry affect the Neurovascular Devices Market in 2025?
Industry rivalry is high. The neurovascular devices market is highly competitive, with a few key players dominating the space. These companies constantly innovate, improving the functionality and precision of devices while also engaging in price competition and securing partnerships with healthcare institutions. The market’s potential for growth continues to attract new players, intensifying the rivalry.
Market Upstream Analysis
What are the key upstream factors affecting the Neurovascular Devices Market in 2025?
Upstream factors include the availability and cost of raw materials such as metals, polymers, and biocompatible materials. Suppliers of advanced technologies, including imaging systems and AI components, also play a significant role in shaping the market. Additionally, regulatory bodies and their approval processes for new materials and technologies can impact the supply chain.
How do suppliers of raw materials impact the Neurovascular Devices Market in 2025?
Suppliers of raw materials have a considerable impact, as the quality and cost of materials directly affect the production of neurovascular devices. Availability of high-quality biocompatible materials and precision components is critical for device performance and safety. Supply chain disruptions or price fluctuations in these raw materials could influence manufacturing timelines and costs.
How do technological advancements in the upstream affect the Neurovascular Devices Market in 2025?
Technological advancements in upstream processes, such as innovations in 3D printing, nanotechnology, and AI, are pivotal. These technologies enable the development of more precise and effective devices. As new manufacturing techniques emerge, they may lower production costs and lead to the creation of more sophisticated neurovascular devices, improving patient outcomes.
How do regulatory and compliance challenges impact the upstream in the Neurovascular Devices Market in 2025?
Regulatory and compliance challenges are critical upstream factors. The complex and rigorous approval processes required for new materials and devices can delay market entry and increase costs. Manufacturers must navigate a maze of regulations, including FDA approvals, ISO standards, and country-specific requirements, which can slow down innovation and production timelines.
How do suppliers of advanced technologies influence the Neurovascular Devices Market in 2025?
Suppliers of advanced technologies, such as imaging systems, robotics, and AI tools, play an increasingly important role in the upstream process. These technologies help improve the accuracy and effectiveness of neurovascular devices, pushing manufacturers to integrate cutting-edge innovations into their products. The cost, availability, and advancement of these technologies can drive competitiveness and product differentiation in the market.
Market Midstream Analysis
What are the key midstream factors impacting the Neurovascular Devices Market in 2025?
Midstream factors include the manufacturing processes, such as assembly, quality control, and testing of neurovascular devices. Additionally, relationships with distributors and partnerships with healthcare institutions play a key role in ensuring efficient product delivery and adoption in clinical settings.
How does the manufacturing process affect the Neurovascular Devices Market in 2025?
The manufacturing process is crucial as it ensures the production of safe, high-quality, and reliable neurovascular devices. Precision, strict adherence to quality control standards, and advanced technologies in manufacturing significantly impact product performance and safety, which directly influences market acceptance and regulatory approvals.
What role do distributors play in the Neurovascular Devices Market in 2025?
Distributors are vital in bridging the gap between manufacturers and healthcare providers. They ensure that neurovascular devices are efficiently delivered to hospitals, clinics, and surgical centers. Strong relationships with distributors can help manufacturers reach a wider customer base and ensure timely availability of products in critical healthcare settings.
How do healthcare partnerships impact the midstream in the Neurovascular Devices Market in 2025?
Partnerships with hospitals, healthcare providers, and research institutions are essential for driving the adoption and use of neurovascular devices. Collaborative efforts in clinical trials, training, and product feedback can enhance device design and functionality, helping manufacturers improve their offerings. These partnerships also facilitate market penetration, especially in emerging markets.
How do regulatory approvals affect the midstream in the Neurovascular Devices Market in 2025?
Regulatory approvals play a critical role in the midstream process, as they ensure that devices meet necessary safety and efficacy standards before they reach the market. Delays in regulatory reviews can slow down product availability, while compliance with global standards is crucial for manufacturers aiming to enter multiple international markets.
Market Downstream Analysis
What are the key downstream factors affecting the Neurovascular Devices Market in 2025?
Downstream factors include the adoption and utilization of neurovascular devices by healthcare providers, such as hospitals and surgical centers. The acceptance of these devices by medical professionals, along with patient outcomes and insurance coverage, plays a major role in shaping market dynamics.
How does the adoption by healthcare providers impact the Neurovascular Devices Market in 2025?
Healthcare providers are central to the downstream process as they directly use these devices in patient treatment. The willingness of hospitals and specialists to adopt new technologies depends on device performance, training support, and cost-effectiveness. Widespread adoption boosts market growth and encourages manufacturers to innovate further.
What role does patient awareness and demand play in the downstream market?
As awareness of neurovascular diseases like strokes grows, patients and their families are increasingly seeking advanced treatment options, influencing demand. Higher patient demand encourages healthcare providers to invest in the latest neurovascular devices, which can further propel market growth and expand the reach of these products.
How does insurance coverage affect the downstream in the Neurovascular Devices Market in 2025?
Insurance coverage and reimbursement policies are critical to the downstream market. If insurance companies recognize and cover the cost of advanced neurovascular devices, patients are more likely to have access to them. Favorable reimbursement policies can also influence healthcare providers’ willingness to purchase and use these devices.
What impact does post-treatment support and training have on the downstream market?
Effective post-treatment support and training for healthcare professionals play a significant role in ensuring the proper use of neurovascular devices. Continued education and support not only help in enhancing treatment outcomes but also foster greater trust in the devices, encouraging wider adoption and better market penetration.
Chapter 1, to describe Neurovascular Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurovascular Devices, with price, sales, revenue and global market share of Neurovascular Devices from 2018 to 2023.
Chapter 3, the Neurovascular Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurovascular Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Neurovascular Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurovascular Devices.
Chapter 14 and 15, to describe Neurovascular Devices sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Neurovascular Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Neurovascular Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Aneurysm Coiling & Embolization Devices
1.3.3 Cerebral Balloon Angioplasty & Stenting Systems
1.3.4 Support Devices
1.3.5 Neurothrombectomy Devices
1.4 Market Analysis by Application
1.4.1 Overview: Global Neurovascular Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Ambulatory Surgical Units
1.5 Global Neurovascular Devices Market Size & Forecast
1.5.1 Global Neurovascular Devices Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Neurovascular Devices Sales Quantity (2018-2029)
1.5.3 Global Neurovascular Devices Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Stryker Corporation
2.1.1 Stryker Corporation Details
2.1.2 Stryker Corporation Major Business
2.1.3 Stryker Corporation Neurovascular Devices Product and Services
2.1.4 Stryker Corporation Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Stryker Corporation Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Neurovascular Devices Product and Services
2.2.4 Johnson & Johnson Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Neurovascular Devices Product and Services
2.3.4 Medtronic Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Medtronic Recent Developments/Updates
2.4 Terumo
2.4.1 Terumo Details
2.4.2 Terumo Major Business
2.4.3 Terumo Neurovascular Devices Product and Services
2.4.4 Terumo Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Terumo Recent Developments/Updates
2.5 Penumbra
2.5.1 Penumbra Details
2.5.2 Penumbra Major Business
2.5.3 Penumbra Neurovascular Devices Product and Services
2.5.4 Penumbra Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Penumbra Recent Developments/Updates
2.6 Microport Scientific Corporation
2.6.1 Microport Scientific Corporation Details
2.6.2 Microport Scientific Corporation Major Business
2.6.3 Microport Scientific Corporation Neurovascular Devices Product and Services
2.6.4 Microport Scientific Corporation Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Microport Scientific Corporation Recent Developments/Updates
2.7 Abbott Vascular
2.7.1 Abbott Vascular Details
2.7.2 Abbott Vascular Major Business
2.7.3 Abbott Vascular Neurovascular Devices Product and Services
2.7.4 Abbott Vascular Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Abbott Vascular Recent Developments/Updates
2.8 W. L. Gore & Associates
2.8.1 W. L. Gore & Associates Details
2.8.2 W. L. Gore & Associates Major Business
2.8.3 W. L. Gore & Associates Neurovascular Devices Product and Services
2.8.4 W. L. Gore & Associates Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 W. L. Gore & Associates Recent Developments/Updates
3 Competitive Environment: Neurovascular Devices by Manufacturer
3.1 Global Neurovascular Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Neurovascular Devices Revenue by Manufacturer (2018-2023)
3.3 Global Neurovascular Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Neurovascular Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Neurovascular Devices Manufacturer Market Share in 2022
3.4.2 Top 6 Neurovascular Devices Manufacturer Market Share in 2022
3.5 Neurovascular Devices Market: Overall Company Footprint Analysis
3.5.1 Neurovascular Devices Market: Region Footprint
3.5.2 Neurovascular Devices Market: Company Product Type Footprint
3.5.3 Neurovascular Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Neurovascular Devices Market Size by Region
4.1.1 Global Neurovascular Devices Sales Quantity by Region (2018-2029)
4.1.2 Global Neurovascular Devices Consumption Value by Region (2018-2029)
4.1.3 Global Neurovascular Devices Average Price by Region (2018-2029)
4.2 North America Neurovascular Devices Consumption Value (2018-2029)
4.3 Europe Neurovascular Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Neurovascular Devices Consumption Value (2018-2029)
4.5 South America Neurovascular Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Neurovascular Devices Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Neurovascular Devices Sales Quantity by Type (2018-2029)
5.2 Global Neurovascular Devices Consumption Value by Type (2018-2029)
5.3 Global Neurovascular Devices Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Neurovascular Devices Sales Quantity by Application (2018-2029)
6.2 Global Neurovascular Devices Consumption Value by Application (2018-2029)
6.3 Global Neurovascular Devices Average Price by Application (2018-2029)
7 North America
7.1 North America Neurovascular Devices Sales Quantity by Type (2018-2029)
7.2 North America Neurovascular Devices Sales Quantity by Application (2018-2029)
7.3 North America Neurovascular Devices Market Size by Country
7.3.1 North America Neurovascular Devices Sales Quantity by Country (2018-2029)
7.3.2 North America Neurovascular Devices Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Neurovascular Devices Sales Quantity by Type (2018-2029)
8.2 Europe Neurovascular Devices Sales Quantity by Application (2018-2029)
8.3 Europe Neurovascular Devices Market Size by Country
8.3.1 Europe Neurovascular Devices Sales Quantity by Country (2018-2029)
8.3.2 Europe Neurovascular Devices Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Neurovascular Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Neurovascular Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Neurovascular Devices Market Size by Region
9.3.1 Asia-Pacific Neurovascular Devices Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Neurovascular Devices Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Neurovascular Devices Sales Quantity by Type (2018-2029)
10.2 South America Neurovascular Devices Sales Quantity by Application (2018-2029)
10.3 South America Neurovascular Devices Market Size by Country
10.3.1 South America Neurovascular Devices Sales Quantity by Country (2018-2029)
10.3.2 South America Neurovascular Devices Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Neurovascular Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Neurovascular Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Neurovascular Devices Market Size by Country
11.3.1 Middle East & Africa Neurovascular Devices Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Neurovascular Devices Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Neurovascular Devices Market Drivers
12.2 Neurovascular Devices Market Restraints
12.3 Neurovascular Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Neurovascular Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neurovascular Devices
13.3 Neurovascular Devices Production Process
13.4 Neurovascular Devices Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neurovascular Devices Typical Distributors
14.3 Neurovascular Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Neurovascular Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neurovascular Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Stryker Corporation Basic Information, Manufacturing Base and Competitors
Table 4. Stryker Corporation Major Business
Table 5. Stryker Corporation Neurovascular Devices Product and Services
Table 6. Stryker Corporation Neurovascular Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Stryker Corporation Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Neurovascular Devices Product and Services
Table 11. Johnson & Johnson Neurovascular Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Medtronic Basic Information, Manufacturing Base and Competitors
Table 14. Medtronic Major Business
Table 15. Medtronic Neurovascular Devices Product and Services
Table 16. Medtronic Neurovascular Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Medtronic Recent Developments/Updates
Table 18. Terumo Basic Information, Manufacturing Base and Competitors
Table 19. Terumo Major Business
Table 20. Terumo Neurovascular Devices Product and Services
Table 21. Terumo Neurovascular Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Terumo Recent Developments/Updates
Table 23. Penumbra Basic Information, Manufacturing Base and Competitors
Table 24. Penumbra Major Business
Table 25. Penumbra Neurovascular Devices Product and Services
Table 26. Penumbra Neurovascular Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Penumbra Recent Developments/Updates
Table 28. Microport Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 29. Microport Scientific Corporation Major Business
Table 30. Microport Scientific Corporation Neurovascular Devices Product and Services
Table 31. Microport Scientific Corporation Neurovascular Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Microport Scientific Corporation Recent Developments/Updates
Table 33. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 34. Abbott Vascular Major Business
Table 35. Abbott Vascular Neurovascular Devices Product and Services
Table 36. Abbott Vascular Neurovascular Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Abbott Vascular Recent Developments/Updates
Table 38. W. L. Gore & Associates Basic Information, Manufacturing Base and Competitors
Table 39. W. L. Gore & Associates Major Business
Table 40. W. L. Gore & Associates Neurovascular Devices Product and Services
Table 41. W. L. Gore & Associates Neurovascular Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. W. L. Gore & Associates Recent Developments/Updates
Table 43. Global Neurovascular Devices Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 44. Global Neurovascular Devices Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Neurovascular Devices Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 46. Market Position of Manufacturers in Neurovascular Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Neurovascular Devices Production Site of Key Manufacturer
Table 48. Neurovascular Devices Market: Company Product Type Footprint
Table 49. Neurovascular Devices Market: Company Product Application Footprint
Table 50. Neurovascular Devices New Market Entrants and Barriers to Market Entry
Table 51. Neurovascular Devices Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Neurovascular Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 53. Global Neurovascular Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 54. Global Neurovascular Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Neurovascular Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Neurovascular Devices Average Price by Region (2018-2023) & (USD/Unit)
Table 57. Global Neurovascular Devices Average Price by Region (2024-2029) & (USD/Unit)
Table 58. Global Neurovascular Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Global Neurovascular Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Global Neurovascular Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Neurovascular Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Neurovascular Devices Average Price by Type (2018-2023) & (USD/Unit)
Table 63. Global Neurovascular Devices Average Price by Type (2024-2029) & (USD/Unit)
Table 64. Global Neurovascular Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 65. Global Neurovascular Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 66. Global Neurovascular Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Neurovascular Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Neurovascular Devices Average Price by Application (2018-2023) & (USD/Unit)
Table 69. Global Neurovascular Devices Average Price by Application (2024-2029) & (USD/Unit)
Table 70. North America Neurovascular Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 71. North America Neurovascular Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 72. North America Neurovascular Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 73. North America Neurovascular Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 74. North America Neurovascular Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 75. North America Neurovascular Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 76. North America Neurovascular Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Neurovascular Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Neurovascular Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Europe Neurovascular Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Europe Neurovascular Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 81. Europe Neurovascular Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 82. Europe Neurovascular Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 83. Europe Neurovascular Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 84. Europe Neurovascular Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Neurovascular Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Neurovascular Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 87. Asia-Pacific Neurovascular Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 88. Asia-Pacific Neurovascular Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 89. Asia-Pacific Neurovascular Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 90. Asia-Pacific Neurovascular Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 91. Asia-Pacific Neurovascular Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 92. Asia-Pacific Neurovascular Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Neurovascular Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Neurovascular Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 95. South America Neurovascular Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 96. South America Neurovascular Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 97. South America Neurovascular Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 98. South America Neurovascular Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 99. South America Neurovascular Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 100. South America Neurovascular Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Neurovascular Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Neurovascular Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 103. Middle East & Africa Neurovascular Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 104. Middle East & Africa Neurovascular Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Middle East & Africa Neurovascular Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Middle East & Africa Neurovascular Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 107. Middle East & Africa Neurovascular Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 108. Middle East & Africa Neurovascular Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Neurovascular Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Neurovascular Devices Raw Material
Table 111. Key Manufacturers of Neurovascular Devices Raw Materials
Table 112. Neurovascular Devices Typical Distributors
Table 113. Neurovascular Devices Typical Customers
List of Figures
Figure 1. Neurovascular Devices Picture
Figure 2. Global Neurovascular Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neurovascular Devices Consumption Value Market Share by Type in 2022
Figure 4. Aneurysm Coiling & Embolization Devices Examples
Figure 5. Cerebral Balloon Angioplasty & Stenting Systems Examples
Figure 6. Support Devices Examples
Figure 7. Neurothrombectomy Devices Examples
Figure 8. Global Neurovascular Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Neurovascular Devices Consumption Value Market Share by Application in 2022
Figure 10. Hospitals Examples
Figure 11. Clinics Examples
Figure 12. Ambulatory Surgical Units Examples
Figure 13. Global Neurovascular Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Neurovascular Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Neurovascular Devices Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Neurovascular Devices Average Price (2018-2029) & (USD/Unit)
Figure 17. Global Neurovascular Devices Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Neurovascular Devices Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Neurovascular Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Neurovascular Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Neurovascular Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Neurovascular Devices Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Neurovascular Devices Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Neurovascular Devices Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Neurovascular Devices Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Neurovascular Devices Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Neurovascular Devices Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Neurovascular Devices Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Neurovascular Devices Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Neurovascular Devices Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Neurovascular Devices Average Price by Type (2018-2029) & (USD/Unit)
Figure 32. Global Neurovascular Devices Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Neurovascular Devices Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Neurovascular Devices Average Price by Application (2018-2029) & (USD/Unit)
Figure 35. North America Neurovascular Devices Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Neurovascular Devices Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Neurovascular Devices Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Neurovascular Devices Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Neurovascular Devices Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Neurovascular Devices Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Neurovascular Devices Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Neurovascular Devices Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Neurovascular Devices Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Neurovascular Devices Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Neurovascular Devices Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Neurovascular Devices Consumption Value Market Share by Region (2018-2029)
Figure 55. China Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Neurovascular Devices Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Neurovascular Devices Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Neurovascular Devices Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Neurovascular Devices Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Neurovascular Devices Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Neurovascular Devices Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Neurovascular Devices Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Neurovascular Devices Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Neurovascular Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Neurovascular Devices Market Drivers
Figure 76. Neurovascular Devices Market Restraints
Figure 77. Neurovascular Devices Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Neurovascular Devices in 2022
Figure 80. Manufacturing Process Analysis of Neurovascular Devices
Figure 81. Neurovascular Devices Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
